QuantX recently became the first-ever computer-aided breast cancer diagnosis system cleared by the FDA for use in radiology, but it's not putting radiologists out of a job any time soon. "Radiology is the backbone of diagnosing many diseases today," said Jeffrey Aronin, chairman and CEO of Paragon Biosciences. "We believe the future is radiologists with technology." The combination of humans and machines apparently works really well. In a clinical study, QuantX helped radiologists interpret MRIs, noting the differences between cancerous and noncancerous breast lesions.
The UK's National Health Service (NHS) has announced what it claims is a world first: a partnership with Amazon's Alexa to offer health advice from the NHS website. Britons who ask Alexa basic health questions like "Alexa, how do I treat a migraine?" The partnership does not add significantly to Alexa's skill-set, but it is an interesting step for the NHS. The UK's Department of Health (DoH) says it hopes the move will reduce the pressure on health professionals in the country, giving people a new way to access reliable medical advice. It will also benefit individuals with disabilities, like sight impairments, who may find it difficult to use computers or smartphones to find the same information.
In a world-first, Amazon has partnered with the UK's health service, the NHS. From this week, its voice-controlled device, Alexa, will give out health advice, and answer common questions such as'Alexa, how do I treat a migraine?' and'Alexa, what are the symptoms of chickenpox?' In response to health-related queries, Alexa will now search the NHS Choices website for health information (and there you were thinking Amazon was all about Prime Day deals). The aim is to ease pressure on the NHS and help those who can't easily access information on the internet – such as the elderly or blind people. Will this partnership with Amazon really end up easing pressure on the health service, or will it lead to data protection issues and misdiagnoses? As we've previously explored, the use of voice interfaces is one of the fastest growing web design trends in recent years, but so far the news has been met with concerns over the appropriateness of using Alexa to deliver this kind of important and sensitive information.
Koios Medical, the leader in ultrasound diagnosis decision support software, announces its second 510(k) clearance from the U.S. Food and Drug Administration (FDA). Koios DS (Decision Support) Breast 2.0 is intended for use to assist physicians analyzing breast ultrasound images and aligns a machine learning generated probability of malignancy with the appropriate BI-RADS category. This milestone is an important step in advancing the company's mission of empowering physicians to improve diagnostic accuracy. Now cleared for use at the point of care (or connected to an image viewer for studies stored on PACS), Koios Medical's advancements represent a huge leap forward in using artificial intelligence in healthcare by bringing the power of deep learning to physicians' fingertips. Koios DS Breast 2.0 represents the most advanced AI-based diagnostic technology for ultrasound image analysis to date.
Not all voice assistants can handle the same requests. We put Siri, Alexa and Google to the test. LONDON -- Alexa will see you now. Britain's health care service is teaming up with Amazon's digital voice assistant to help answer medical queries with advice from the service's official website. Critics, however, warn about risks to data privacy.
Employees and contractors at the Centers of Medicare and Medicaid Services spend countless hours every year reviewing thousands of medical records to ensure the accuracy of Medicare Advantage payments. An automated intake tool is working to change that. Using emerging technologies such as robotic process automation, optical character recognition, machine learning and artificial intelligence, KPMG's Intake Process Automation Tool ingests records as they are submitted and identifies potential problems according to set parameters, submission rules and coding guidance. Specifically, RPA orchestrates the steps of the intake process, OCR digitizes the scanned document and then AI and machine learning are applied to understand the document and extract the information necessary to validate the information. Intake PA stands to save CMS time and money, said Payam Mousavi, KPMG's lead director for intelligent automation for governments and the technical lead for the CMS project.
The NHS has teamed up with Amazon to allow elderly people, blind people and other patients who cannot easily search for health advice on the internet to access the information through the AI-powered voice assistant Alexa. The health service hopes patients asking Alexa for health advice will ease pressure on the NHS, with Amazon's algorithm using information from the NHS website to provide answers to questions such as: "Alexa, how do I treat a migraine?"; 'Alexa, what are the symptoms of flu?'; and "Alexa what are the symptoms of chickenpox?" The Department of Health (DoH) said it would empower patients and hopefully reduce the pressure on the NHS by providing reliable information on common illnesses. The health secretary, Matt Hancock, said: "Technology like this is a great example of how people can access reliable, world-leading NHS advice from the comfort of their home, reducing the pressure on our hardworking GPs and pharmacists."
People will be able to get expert health advice using Amazon Alexa devices under a partnership with the NHS, the government has announced. From this week, the voice-assisted technology is automatically searching the NHS Choices website when UK users ask for health-related advice. Previously the device provided information from a range of sources. The Department of Health in England said it could provide valuable support and even reduce demand on the NHS. The partnership was first announced last year and now talks are under way with other companies, including Microsoft, to set up similar arrangements.
The joint effort comes as health systems are stepping up adoption and investment in data analytics, including predictive analytics and AI. In recent survey of CIOs, CTOs and chief analytics officers conducted by the Deloitte Center for Health Solutions, 84% said such technology will be extremely important to their organization's strategy over the next three years. Other healthcare sectors are investing in AI as well, giving rise to potential safety, efficacy and ethical issues as the technology is more frequently used. One year ago, FDA approved the first autonomous AI diagnostic system for sale in the U.S. The cloud-based IDx-DR software detects diabetic retinopathy in images taken by retinal cameras. And in February, Verily, the life sciences arm of Google parent Alphabet, launched an eye disease screening algorithm at Aravind Eye Hospital in Madurai, India.
Often, large corporations – which may dominate a market sector like the medical imaging field, which includes computerized tomography (CT), magnetic resonance imaging (MRI) and radiography – are so large they are not able to adapt to new, even disruptive, technologies. Sometimes these are spun off into other companies, as is the case with Harris Corporation and AuthenTec, which developed the fingerprint technology used on Apple phones. Other times, a smaller, nimbler company may emerge that introduces something transformative. Such may be the case with Central Florida's Omega Medical Imaging led by Brian Fleming, which recently received FDA clearance for its FluoroShield system. EW: I want to talk about how you became CEO of Omega, but first, explain the FluoroShield system.